β-Adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: Regulation by β- but not α1-adrenergic stimulation

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 396-401

  Iaccarino, Guido ^a   Dolber, Paul C ^a   Lefkowitz, Robert J ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Catecholamines; Desensitization; G protein coupled receptor kinases; Myocardial hypertrophy; Adrenergic receptor

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; ISOPRENALINE; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR KINASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHENYLEPHRINE;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART PERFORMANCE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOLEMMA; ANIMAL; BODY WEIGHT; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; GENETICS; HEART; HEART MUSCLE; HEART VENTRICLE; INFUSION PUMP; METABOLISM; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOASSAY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADENYLATE CYCLASE; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; BETA-ADRENERGIC RECEPTOR KINASE; BODY WEIGHT; CARDIOMEGALY; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GTP-BINDING PROTEINS; HEART; HEART VENTRICLES; INFUSION PUMPS; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MYOCARDIUM; ORGAN SIZE; PHENYLEPHRINE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 0032617113     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.396     Document Type: Article

References (24)

1. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
2. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972;287:781-787.
3. Bohm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M., Erdmann E. β-Adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension. 1994;24:653-662.
4. Choi D-J, Koch WJ, Hunter JJ, Rockman HA. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-17229.
5. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or an βARK inhibitor. Science. 1995;268: 1350-1353.
6. Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, Lefkowitz RJ, Caron MG, Koch WJ. Control of myocardial contractile function by the level of β-adrenergic receptor kinase 1 in gene-targeted mice. J Biol Chem. 1998;273:18180-18184.
7. Ungerer M, Kessebohm K, Kronsbein K, Lohse MJ, Richardt G. Activation of β-adrenergic receptor kinase during myocardial ischemia. Circ Res. 1996;79:455-460.
8. Gros R, Benovic JL, Tan CM, Feldman RD. G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest. 1997;99: 2087-2093.
9. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ. Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circulation. 1993;87:454-463.
10. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913-919.
11. Lembo G, Rendina V, Iaccarino G, De Luca N, Ricciardelli B, Volpe M, Trimarco B. Digitalis restores the forearm sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1993;11:1395-1402.
12. LaMorte VJ, Thorburn J, Absher D, Spiegel A, Brown JH, Chien KR, Feramisco JR, Knowlton KU. Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem. 1994;269:13490-13496.
13. Stiles GL, Lefkowitz RJ. Cardiac adrenergic receptors. Annu Rev Med. 1984;35:149-164.
14. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. α-, and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells, fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an α1-mediated response. J Biol Chem. 1990;265:13809-13817.
15. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ. Myocardial expression of a constitutively active α1b-AR in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994;91:10109-10113.
16. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade. Circulation. 1998;98: 1783-1789.
17. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, Lefkowitz RJ, Koch WJ. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A. 1997;94:12100-12105.
18. Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, Koch W J. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci U S A. 1996; 93:9954-9959.
19. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billmgham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
20. Karliner JS, Stevens MB, Honbo N, Hoffman JI. Effects of acute ischemia in the dog on myocardial blood flow, β receptors, and adenylate cyclase activity with and without chronic β blockade. J Clin Invest. 1989;83:474-481.
21. Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension. 1990;16:107-120.
22. Wilson PW. An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure. Am J Cardiol. 1997;80: 3J-8J.
23. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972;287:781-787.
24. Anand-Srivastava MB. G-proteins and adenylyl cyclase signalling in hypertension. Mol Cell Biochem. 1996;157:163-170.